Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00462852 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pancreatic Cancer
Thromboembolism

Interventions

DRUG: dalteparin
DRUG: gemcitabine hydrochloride
OTHER: diagnostic laboratory biomarker analysis

Sponsor

Hull University Teaching Hospitals NHS Trust